vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $93.7M, roughly 1.3× Ranpak Holdings Corp.). On growth, Ranpak Holdings Corp. posted the faster year-over-year revenue change (2.3% vs -1.4%). Over the past eight quarters, Ranpak Holdings Corp.'s revenue compounded faster (13.7% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

CLB vs PACK — Head-to-Head

Bigger by revenue
CLB
CLB
1.3× larger
CLB
$121.8M
$93.7M
PACK
Growing faster (revenue YoY)
PACK
PACK
+3.7% gap
PACK
2.3%
-1.4%
CLB
Faster 2-yr revenue CAGR
PACK
PACK
Annualised
PACK
13.7%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
PACK
PACK
Revenue
$121.8M
$93.7M
Net Profit
$5.1M
Gross Margin
39.0%
Operating Margin
1.5%
-1.0%
Net Margin
4.2%
Revenue YoY
-1.4%
2.3%
Net Profit YoY
EPS (diluted)
$0.11
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
PACK
PACK
Q1 26
$121.8M
Q4 25
$138.3M
$93.7M
Q3 25
$134.5M
$83.6M
Q2 25
$130.2M
$77.8M
Q1 25
$123.6M
$77.6M
Q4 24
$129.2M
$91.6M
Q3 24
$134.4M
$78.6M
Q2 24
$130.6M
$72.8M
Net Profit
CLB
CLB
PACK
PACK
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$-10.4M
Q2 25
$10.6M
$-7.5M
Q1 25
$-154.0K
$-10.9M
Q4 24
$7.4M
Q3 24
$11.7M
$-8.1M
Q2 24
$9.0M
$5.5M
Gross Margin
CLB
CLB
PACK
PACK
Q1 26
Q4 25
20.8%
39.0%
Q3 25
22.0%
41.1%
Q2 25
20.3%
37.1%
Q1 25
19.5%
39.8%
Q4 24
17.8%
45.2%
Q3 24
20.5%
43.8%
Q2 24
21.2%
43.5%
Operating Margin
CLB
CLB
PACK
PACK
Q1 26
1.5%
Q4 25
11.5%
-1.0%
Q3 25
15.6%
-6.8%
Q2 25
11.7%
-12.5%
Q1 25
3.6%
-10.3%
Q4 24
11.0%
1.5%
Q3 24
14.7%
-5.3%
Q2 24
12.3%
-7.1%
Net Margin
CLB
CLB
PACK
PACK
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
-12.4%
Q2 25
8.2%
-9.6%
Q1 25
-0.1%
-14.0%
Q4 24
5.7%
Q3 24
8.7%
-10.3%
Q2 24
6.9%
7.6%
EPS (diluted)
CLB
CLB
PACK
PACK
Q1 26
$0.11
Q4 25
$0.11
$-0.11
Q3 25
$0.30
$-0.12
Q2 25
$0.22
$-0.09
Q1 25
$0.00
$-0.13
Q4 24
$0.15
$-0.13
Q3 24
$0.25
$-0.10
Q2 24
$0.19
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
PACK
PACK
Cash + ST InvestmentsLiquidity on hand
$22.8M
$63.0M
Total DebtLower is stronger
$401.9M
Stockholders' EquityBook value
$275.1M
$534.9M
Total Assets
$587.7M
$1.1B
Debt / EquityLower = less leverage
0.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
PACK
PACK
Q1 26
$22.8M
Q4 25
$22.7M
$63.0M
Q3 25
$25.6M
$49.9M
Q2 25
$31.2M
$49.2M
Q1 25
$22.1M
$65.5M
Q4 24
$19.2M
$76.1M
Q3 24
$21.5M
$69.5M
Q2 24
$17.7M
$65.1M
Total Debt
CLB
CLB
PACK
PACK
Q1 26
Q4 25
$110.3M
$401.9M
Q3 25
$114.1M
$403.1M
Q2 25
$124.6M
$403.1M
Q1 25
$124.4M
$405.2M
Q4 24
$126.1M
$406.4M
Q3 24
$139.9M
$403.2M
Q2 24
$147.6M
$396.1M
Stockholders' Equity
CLB
CLB
PACK
PACK
Q1 26
$275.1M
Q4 25
$266.0M
$534.9M
Q3 25
$271.3M
$537.8M
Q2 25
$261.3M
$539.0M
Q1 25
$253.4M
$544.1M
Q4 24
$246.6M
$548.1M
Q3 24
$250.7M
$564.3M
Q2 24
$240.3M
$566.2M
Total Assets
CLB
CLB
PACK
PACK
Q1 26
$587.7M
Q4 25
$584.0M
$1.1B
Q3 25
$591.4M
$1.1B
Q2 25
$602.1M
$1.1B
Q1 25
$591.5M
$1.1B
Q4 24
$585.1M
$1.1B
Q3 24
$600.5M
$1.1B
Q2 24
$597.8M
$1.1B
Debt / Equity
CLB
CLB
PACK
PACK
Q1 26
Q4 25
0.41×
0.75×
Q3 25
0.42×
0.75×
Q2 25
0.48×
0.75×
Q1 25
0.49×
0.74×
Q4 24
0.51×
0.74×
Q3 24
0.56×
0.71×
Q2 24
0.61×
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
PACK
PACK
Operating Cash FlowLast quarter
$4.0M
$19.5M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
PACK
PACK
Q1 26
$4.0M
Q4 25
$7.9M
$19.5M
Q3 25
$8.5M
$8.5M
Q2 25
$13.9M
$-3.6M
Q1 25
$6.7M
$-1.3M
Q4 24
$20.6M
$6.5M
Q3 24
$13.1M
$10.1M
Q2 24
$17.1M
$19.6M
Free Cash Flow
CLB
CLB
PACK
PACK
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
PACK
PACK
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
PACK
PACK
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
PACK
PACK
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×
3.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

Related Comparisons